Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.

Clozapine-induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness / Accinni, Tommaso; Frascarelli, Marianna; Ghezzi, Francesco; Panzera, Alessia; Buzzanca, Antonino; Fanella, Martina; DI BONAVENTURA, Carlo; Carlone, Luca; Girardi, Nicoletta; Pasquini, Massimo; DI FABIO, Fabio. - In: CLINICAL CASE REPORTS: OPEN ACCESS. - ISSN 2582-5038. - (2021). [10.1002/ccr3.4134]

Clozapine-induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness

Tommaso Accinni
Primo
Writing – Original Draft Preparation
;
Marianna Frascarelli
Secondo
Writing – Review & Editing
;
Francesco Ghezzi
Conceptualization
;
Alessia Panzera
Investigation
;
Antonino Buzzanca
Methodology
;
Martina Fanella
Investigation
;
Carlo Di Bonaventura
Supervision
;
Luca Carlone
Investigation
;
Nicoletta Girardi
Investigation
;
Massimo Pasquini
Penultimo
Supervision
;
Fabio Di Fabio
Ultimo
Supervision
2021

Abstract

Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.
2021
genetics; pharmacology; psychiatry
01 Pubblicazione su rivista::01i Case report
Clozapine-induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness / Accinni, Tommaso; Frascarelli, Marianna; Ghezzi, Francesco; Panzera, Alessia; Buzzanca, Antonino; Fanella, Martina; DI BONAVENTURA, Carlo; Carlone, Luca; Girardi, Nicoletta; Pasquini, Massimo; DI FABIO, Fabio. - In: CLINICAL CASE REPORTS: OPEN ACCESS. - ISSN 2582-5038. - (2021). [10.1002/ccr3.4134]
File allegati a questo prodotto
File Dimensione Formato  
Accinni_Clozapine-induced gastroesophageal rumination_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 116.91 kB
Formato Adobe PDF
116.91 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1615695
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact